RidNova is a biopharmaceutical company dedicated to addressing health challenges and driving innovation in pharmaceuticals, biosimilars, and biologics, to improve patient outcomes. We specialise in formulation development, formulation consulting, analytical and commercial manufacturing, leveraging state-of-the-art technologies and extensive industry expertise. We offer comprehensive product and dossier development and formulation, regulatory & CMC consultancy, advisory services in complex formulation, biosimilars, biologicals, 505 b (2)/hybrid, differentiated, innovative, value-added formulations to Pharma, CDMO, small biotech/startups for formulation, as well as guidance on regulatory strategy. RidNova also provides services in IP, regulatory submissions, post-launch activities and strategic publication planning to support the successful introduction and positioning of pharmaceutical assets in the market.